E75.22
Gaucher disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Gaucher disease is a rare inherited disorder in which certain fatty substances, called glucocerebrosides, accumulate in cells and certain organs. This buildup can cause various symptoms and organ enlargement, primarily affecting the liver, spleen, bones, and bone marrow. The condition is caused by a deficiency of an enzyme called glucocerebrosidase, which is necessary to break down these fatty substances. The severity and symptoms vary widely among individuals, ranging from mild to more severe forms.
Causes & Symptoms
Clinical Causes: Inheritance of mutations in the GBA gene Autosomal recessive genetic pattern, requiring both parents to pass on the defective gene No environmental factors are known to directly cause Gaucher disease
Key Symptoms: Enlarged spleen (splenomegaly) Enlarged liver (hepatomegaly) Bone pain and fractures Fatigue and anemia Easy bruising or bleeding Difficulty walking due to bone crises Growth delays in children (in some cases) Respiratory issues in severe cases Lymphadenopathy (enlarged lymph nodes)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, blood tests, and genetic studies. Key diagnostic steps include:
Treatment Protocols: While there is no universal cure for Gaucher disease, several management options can help control symptoms and prevent complications:
Clinical Advice & FAQs
Billing Guidance
Is E75.22 a billable ICD-10 code?
Yes, E75.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E75.22?
Clinical documentation must specify the nature of Gaucher disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference